Related Experiment Video
Updated: Mar 19, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
vToxiNet: a biologically constrained deep learning framework for interpretable prediction of drug-induced
Xuelian Jia1, Tong Wang1, Daniel P Russo2
1Center for Biomedical Informatics and Genomics, School of Medicine, Tulane University, New Orleans, Louisiana, USA.
Abstract:
Hepatotoxicity remains a leading cause of drug attrition and post-marketing withdrawal, resulting from diverse and complex toxicity mechanisms. Traditional in vitro models can only capture a limited subset of toxicity pathways, and animal studies face translational and ethical limitations. Regulatory agencies have therefore promoted new approach methodologies, including human-relevant assays, omics technologies, and computational models to improve predictive toxicology and support evidence-based decision-making. However, most machine learning models for hepatotoxicity either rely solely on chemical structure or operate as black boxes, limiting mechanistic interpretability and broader applicability. Here, we introduce the virtual toxicity network (vToxiNet), a biologically constrained deep learning framework that embeds systems toxicology knowledge directly into neural network architecture for interpretable hepatotoxicity prediction. vToxiNet integrates chemical descriptors, high-throughput assay responses, transcriptomic signatures, and Reactome pathway hierarchy to construct a virtual adverse outcome pathway network. Across cross-validation and multiple external validation datasets, vToxiNet demonstrates robust predictive performance and generalizes to previously unseen chemicals. Importantly, interpretation of vToxiNet enables gene and pathway-level attribution, supporting mechanism-informed hazard characterization and chemical prioritization. These results demonstrate that encoding biological hierarchy as architectural constraints enables both predictive accuracy and mechanistic insight, establishing a generalizable framework for modeling complex biological outcomes.
Insights
A new deep learning framework, virtual toxicity network (vToxiNet), improves drug-induced liver injury (hepatotoxicity) prediction by integrating biological pathways. This interpretable model enhances chemical safety assessment and mechanistic understanding.
Area of Science:
- Toxicology
- Computational Biology
- Drug Development
Background:
- Hepatotoxicity is a major challenge in drug development, leading to high attrition rates.
- Current predictive models, including in vitro assays and animal studies, have limitations in accuracy, translatability, and ethics.
- There is a need for improved, interpretable computational methods for predicting drug-induced liver injury.
Purpose of the Study:
- To introduce the virtual toxicity network (vToxiNet), a novel deep learning framework for interpretable hepatotoxicity prediction.
- To integrate systems toxicology knowledge into a deep learning architecture for enhanced predictive accuracy.
- To provide mechanistic insights into hepatotoxicity through gene and pathway-level attribution.
Main Methods:
- Developed vToxiNet, a biologically constrained deep learning framework.
- Integrated chemical descriptors, high-throughput assay data, transcriptomic signatures, and Reactome pathway information.
- Constructed a virtual adverse outcome pathway network within the deep learning architecture.
Main Results:
- vToxiNet demonstrated robust predictive performance across cross-validation and external datasets.
- The model generalized well to previously unseen chemicals.
- Interpretation of vToxiNet enabled gene and pathway-level attribution for mechanistic understanding.
Conclusions:
- Encoding biological hierarchy as architectural constraints in deep learning improves predictive accuracy and mechanistic interpretability for hepatotoxicity.
- vToxiNet offers a generalizable framework for modeling complex biological outcomes, supporting mechanism-informed hazard characterization and chemical prioritization.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Drug toxicity: Idiosyncratic Reactions
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Drug Toxicity: Dose-Dependent Reactions

